FRATES JAMES M — SEC insider filings
SEC reporting owner CIK 1235598. 34 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2021-06-11 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 41,810 shares, $201,103 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 21 legs across 13 filings — 191,722 shares, $5,076,680 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 30,796 shares @ $31.86 ($981,139) in Amylyx Pharmaceuticals, Inc., filed 2023-03-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | 26 | 1 leg · 40,000 sh · $101,368 | 21 legs · 191,722 sh · $5,076,680 | 33 |
| Sage Therapeutics, Inc. (SAGE) | Director | 8 | 1 leg · 1,810 sh · $99,735 | — | 9 |
Insider filings — FRATES JAMES M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Option exercise (M): 20,000 @ $6.88 · Sale (S): 7,700 @ $29.39 · Sale (S): 12,300 @ $30.11 · Option exercise (M): 20,000 @ $6.88 · Sale (S): 12,800 @ $30.32 · Sale (S): 7,200 @ $30.97 · +2 more | EDGAR |
| 2026-09-14 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 9,768 @ $32.27 · Sale (S): 1,042 @ $33.23 | EDGAR |
| 2026-08-20 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 22,807 @ $0 | EDGAR |
| 2026-03-09 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 95,990 @ $0 · Grant/award (A): 143,985 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 7,909 @ $14.52 | EDGAR |
| 2026-02-04 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 3,557 @ $14.65 | EDGAR |
| 2026-01-08 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 3,326 @ $11.11 | EDGAR |
| 2025-10-02 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 10,558 @ $14.65 | EDGAR |
| 2025-07-31 | 4 | Sage Therapeutics, Inc. (SAGE) | Code (U): 2,845 · Disposition to issuer (D): 19,154 (derivative) · Disposition to issuer (D): 21,500 (derivative) | EDGAR |
| 2025-06-13 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 21,500 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 10,896 @ $3.47 | EDGAR |
| 2025-03-10 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 68,420 @ $0 · Grant/award (A): 102,630 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase (P): 40,000 @ $2.53 | EDGAR |
| 2024-09-05 | 4/A | Amylyx Pharmaceuticals, Inc. (AMLX) | Option exercise (M): 18,165 @ $6.88 · Option exercise (M): 18,165 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-04-18 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 91,180 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 1,792 @ $18.73 | EDGAR |
| 2024-02-28 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 2,716 @ $16.33 | EDGAR |
| 2024-01-04 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 4,925 (derivative) @ $0 | EDGAR |
| 2023-11-02 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift (G): 11,072 @ $0 | EDGAR |
| 2023-08-24 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Option exercise (M): 18,165 @ $6.88 · Option exercise (M): 18,165 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-05-18 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Option exercise (M): 32,500 @ $6.88 · Sale (S): 32,000 @ $26.93 · Sale (S): 500 @ $27.60 · Option exercise (M): 32,500 (derivative) @ $0 | EDGAR |
| 2023-04-26 | 4/A | Amylyx Pharmaceuticals, Inc. (AMLX) | Conversion (C): 19,482 @ $0 · Conversion (C): 19,482 (derivative) @ $0 | EDGAR |
| 2023-03-24 | 4/A | Amylyx Pharmaceuticals, Inc. (AMLX) | Option exercise (M): 32,500 @ $6.88 · Sale (S): 30,796 @ $31.86 · Sale (S): 1,704 @ $32.46 · Grant/award (A): 21,667 @ $0 · Grant/award (A): 97,500 (derivative) @ $0 · Option exercise (M): 32,500 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 30,796 @ $31.86 · Sale (S): 1,704 @ $32.46 · Grant/award (A): 21,667 @ $0 · Grant/award (A): 97,500 (derivative) @ $0 | EDGAR |
| 2023-01-10 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 1,836 @ $36.08 · Sale (S): 822 @ $36.79 | EDGAR |
| 2023-01-04 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Option exercise (M): 5,000 @ $6.88 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 9,947 (derivative) @ $0 | EDGAR |
| 2022-03-28 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 31,667 @ $0 · Grant/award (A): 142,500 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Sage Therapeutics, Inc. (SAGE) | Purchase (P): 1,810 @ $55.10 | EDGAR |
| 2021-06-11 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1235598 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs